This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Anemia, Sickle Cell
and you are
over 10
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether alpha-lipoic acid and acetyl-L-carnitine will lower systemic inflammation in patients with Sickle Cell Disease by reducing oxidative stress, which will result in a decrease in the frequency of vaso-occlusive pain episodes and improve their quality of life.

Provided treatments

  • : alpha-lipoic acid and acetyl-L-carnitine
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01054768. The sponsor of the trial is UCSF Benioff Children’s Hospital Oakland and it is looking for 42 volunteers for the current phase.
Official trial title:
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease